Is it growing?
Is XERS growing?
Xeris Biopharma Holdings, Inc. has grown revenue 37% a year over three years and 71% a year over five.
+37%
Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · compounding fast · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +71%
Revenue growth, 5-year rate · +37% over three · growth has slowed since the five-year average
- Years of annual history on file
- 6
Years of annual history on file · FY2020 to FY2025, as filed
Details›
- Revenue FY2021
- $50M
- Revenue FY2022
- $110M
- Revenue FY2023
- $164M
- Revenue FY2024
- $203M
- Revenue FY2025
- $292M
Annual income statements as filed with the SEC.
Drug Manufacturers - Specialty & Generic
Ranks #12 of 28 by Smart Score